Abstract
In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA or RNA strand to localize a specific DNA or RNA sequence on a chromosome or section of tissue (in-situ) fixed on a slide. Flourescence in-situ hybridization (FISH) technique facilitates the localization of genes to different chromosomal locations. It is extensively applied as a gene mapping tool for identification and validation of cytogenetic aberrations identified through comparative genomic hybridization (CGH) on large cohort of archival samples in a tissue microarray format. The discovery of cytogenetic aberrations in cancer has led to the development of quite a few FDA approved molecularly targeted drugs for the management of patients undergoing cancer treatment. FISH technique is extensively utilized as a predictor of responsiveness to treatment with targeted inhibitors, residual disease monitoring and also in noninvasive methods for the detection of tumor cells. Furthermore detection of circulating tumor cells can be detected which have metastatic potential with poor survival prospects. With the development of high throughput technologies like comparative genomic hybridization CGH and next-generation DNA sequencing, human pathology archival specimens of human tumors in various stages of development, can be utilized in the post-human-genome-sequencing era to obtain diagnostic and therapeutic guidance. This article will discuss the extensive application of FISH in diagnosis, prognosis and therapeutic monitoring of cancer.
Keywords: FISH, cancer diagnosis, cancer therapy, molecular tool
Current Medicinal Chemistry
Title:In-Situ Hybridization as a Molecular Tool in Cancer Diagnosis and Treatment
Volume: 19 Issue: 22
Author(s): Z. Jehan, S. Uddin and K. S. Al-Kuraya
Affiliation:
Keywords: FISH, cancer diagnosis, cancer therapy, molecular tool
Abstract: In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA or RNA strand to localize a specific DNA or RNA sequence on a chromosome or section of tissue (in-situ) fixed on a slide. Flourescence in-situ hybridization (FISH) technique facilitates the localization of genes to different chromosomal locations. It is extensively applied as a gene mapping tool for identification and validation of cytogenetic aberrations identified through comparative genomic hybridization (CGH) on large cohort of archival samples in a tissue microarray format. The discovery of cytogenetic aberrations in cancer has led to the development of quite a few FDA approved molecularly targeted drugs for the management of patients undergoing cancer treatment. FISH technique is extensively utilized as a predictor of responsiveness to treatment with targeted inhibitors, residual disease monitoring and also in noninvasive methods for the detection of tumor cells. Furthermore detection of circulating tumor cells can be detected which have metastatic potential with poor survival prospects. With the development of high throughput technologies like comparative genomic hybridization CGH and next-generation DNA sequencing, human pathology archival specimens of human tumors in various stages of development, can be utilized in the post-human-genome-sequencing era to obtain diagnostic and therapeutic guidance. This article will discuss the extensive application of FISH in diagnosis, prognosis and therapeutic monitoring of cancer.
Export Options
About this article
Cite this article as:
Jehan Z., Uddin S. and S. Al-Kuraya K., In-Situ Hybridization as a Molecular Tool in Cancer Diagnosis and Treatment, Current Medicinal Chemistry 2012; 19 (22) . https://dx.doi.org/10.2174/092986712801661031
DOI https://dx.doi.org/10.2174/092986712801661031 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: Molecular Mechanisms of Action
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Small Molecules with EGFR-TK Inhibitor Activity
Current Drug Targets A Pan-Cancer Review of <i>ALK</i> Mutations: Implications for Carcinogenesis and Therapy
Current Cancer Drug Targets Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer
Current Cancer Drug Targets Apoptosis-related BCL2-family Members: Key Players in Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Herbal Compounds and Toxins Modulating TRP Channels
Current Neuropharmacology Molecular Link Mechanisms between Inflammation and Cancer
Current Pharmaceutical Design Importance of Dietary Supplements to the Health
Current Nutrition & Food Science SENP1 as A Biomarker for the Diagnosis of Cancer: Review of the Science and Published Patents
Recent Patents on Biomarkers Decoding the Knots of Initiation of Oncogenic Epithelial-Mesenchymal Transition in Tumor Progression
Current Cancer Drug Targets Growth Retardation of Poorly Transfectable Tumor by Multiple Injections of Plasmids Encoding PE40 Based Targeted Toxin Complexed with Polyethylenimine
Current Gene Therapy The Role of PET/CT and SPECT/CT in Oncology Drug Development
Current Molecular Imaging (Discontinued) Combined Transarterial Chemoembolization with Microwave Ablation <i>versus</i> Microwave Alone for Treatment of Medium Sized Hepatocellular Carcinoma
Current Cancer Drug Targets Na<sup>+</sup>/K<sup>+</sup> ATPase Inhibitors in Cancer
Current Drug Targets The Neuroendocrine Component in Bladder Tumors
Current Medicinal Chemistry Current and Future Drugs for Appetite Regulation and Obesity Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Duration of Dual Antiplatelet Therapy After Coronary Stenting
Current Pharmaceutical Design Recent Progress of Small Molecular VEGFR Inhibitors as Anticancer Agents
Mini-Reviews in Medicinal Chemistry Muscarinic Acetylcholine Receptors: New Potential Therapeutic Targets in Antinociception and in Cancer Therapy
Recent Patents on CNS Drug Discovery (Discontinued) Effect of Administration Route on the Biodistribution and Shedding of Replication-Deficient AAV2: A Qualitative Modelling Approach
Current Gene Therapy